Dubai Lab Tests Top Services
Search Box (All Fields Optional)
Showing 1081 – 1100 out of 1141
Page 55 out of 58
| Thumbnails | Products | Price | Quantity | Action | |
|---|---|---|---|---|---|
|
|
 |
MTRR A66G Genetic Test – Personalized Health & Methylation Analysis
The MTRR A66G test is a genetic screening tool that identifies a specific variant (A66G) in the MTRR gene, which plays a crucial role in folate metabolism and homocysteine regulation. Key features include accurate DNA analysis, easy sample collection (typically via saliva or cheek swab), and fast turnaround time. |
د.إ1,520.00
|
|
|
|
|
 |
د.إ1,520.00
|
|
||
|
|
|
د.إ1,520.00
|
|
||
|
|
|
د.إ1,520.00
|
|
||
|
|
|
د.إ3,200.00
|
|
||
|
|
 |
Life Geno DNA Wellness Test – Comprehensive Genetic Health & Fitness Screening Panel
The Life Geno-DNA Based Comprehensive Wellness Screening Panel is an advanced genetic testing solution that analyzes your DNA to provide personalized insights into your overall health, wellness, and disease risk. Key features include in-depth analysis of genetic markers related to nutrition, fitness, metabolism, sleep, stress, and predisposition to chronic conditions. |
د.إ3,750.00
|
|
|
|
|
 |
Y Chromosome Microdeletion Test for Men – Accurate Male Infertility Screening
The Y Chromosome Microdeletion (YCMD) Blood Test is a specialized genetic screening designed exclusively for males to detect microdeletions in the Y chromosome, a key factor in male infertility. This test identifies deletions in the AZF (Azoospermia Factor) regions, which are crucial for sperm production. |
د.إ2,800.00
|
|
|
|
|
 |
Mitochondrial DNA Sequencing | High-Accuracy mtDNA Analysis for Research & Medicine
Mitochondrial DNA (mtDNA) Sequencing provides high-resolution analysis of mitochondrial genomes, enabling precise identification of genetic variations. Key features include full-length mtDNA sequencing, high accuracy, and deep coverage, ensuring reliable detection of mutations and heteroplasmy. Benefits include applications in ancestry research, forensic identification, disease association studies, and evolutionary biology. |
د.إ3,750.00
|
|
|
|
|
 |
Whole Exome Sequencing
Whole Exome Sequencing (WES) is a powerful genetic testing method that sequences all protein-coding regions (exons) of the genome, covering approximately 1-2% of the DNA where most disease-causing mutations occur. It offers a cost-effective alternative to whole genome sequencing while providing high-depth coverage for accurate variant detection. WES enables the identification of genetic mutations linked to inherited disorders, cancer, and rare diseases, making it a valuable tool for clinical diagnostics, personalized medicine, and research. |
د.إ5,375.00
|
|
|
|
|
 |
ALK Fusion – FISH
ALK Fusion – FISH is a fluorescence in situ hybridization (FISH) test designed to detect ALK gene rearrangements in tumor samples, primarily for non-small cell lung cancer (NSCLC) patients. Key features include high sensitivity and specificity, FDA approval for clinical diagnostics, and direct visualization of ALK gene fusions at the cellular level. |
د.إ3,300.00
|
|
|
|
|
 |
ROS1 FISH Test – Accurate Genetic Testing for Targeted Cancer Therapy
The **Ros1 – Fish Test** is a highly sensitive and reliable fluorescence in situ hybridization (FISH) assay designed for the detection of **ROS1 gene rearrangements** in tumor samples. This test is crucial for identifying patients who may benefit from targeted therapies, particularly in **non-small cell lung cancer (NSCLC)**. Key features include **high specificity and accuracy**, rapid turnaround time, and **direct visualization of gene rearrangements** at the cellular level. Its benefits include **early and precise diagnosis**, enabling personalized treatment decisions and improving patient outcomes. The **unique selling point** of the Ros1 – Fish Test is its **proven clinical utility in guiding targeted therapy selection**, making it an essential tool for oncologists and pathologists in precision medicine. |
د.إ3,750.00
|
|
|
|
|
 |
PD-L1 (22C3) Dako CPS IHC Test – Accurate Immunohistochemistry for Cancer Diagnosis
The PD-L1 (22C3) Dako CPS (IHC) test is an immunohistochemistry (IHC) assay designed to assess PD-L1 expression in tumor and immune cells using the Combined Positive Score (CPS). It is FDA-approved as a companion diagnostic for multiple cancer therapies, ensuring precise patient selection for immune checkpoint inhibitors. The test utilizes the 22C3 monoclonal antibody, providing high sensitivity and specificity in detecting PD-L1 expression. Its standardized scoring system (CPS) enhances reproducibility and clinical decision-making, making it a trusted tool for oncologists. The Dako platform ensures consistent, high-quality staining, supporting accurate and reliable results for personalized cancer treatment. |
د.إ3,500.00
|
|
|
|
|
 |
HER-2/NEU – FISH Test
The HER-2/NEU – FISH Test is a highly precise diagnostic tool used to detect HER-2 gene amplification in breast cancer and other malignancies. Utilizing Fluorescence In Situ Hybridization (FISH) technology, it provides accurate, reliable, and early detection of HER-2 status, which is crucial for determining targeted therapy eligibility, such as Herceptin (trastuzumab) treatment. This test offers higher sensitivity and specificity compared to immunohistochemistry (IHC), reducing false-positive or false-negative results. Its rapid turnaround time and clinically validated methodology make it a gold standard for personalized cancer treatment, ensuring optimal therapeutic decisions and improved patient outcomes. |
د.إ2,820.00
|
|
|
|
|
 |
Oncotype DX Breast Cancer Test – Personalized Risk Assessment & Treatment Guidance
The Oncotype DX Breast Cancer (ML) Test is a genomic assay that analyzes the activity of 21 genes in a breast cancer tumor to predict the risk of recurrence and the potential benefit of chemotherapy. Designed for early-stage, hormone receptor-positive, HER2-negative breast cancer patients, it provides a Recurrence Score® result that helps guide personalized treatment decisions. Key benefits include reducing unnecessary chemotherapy, improving patient outcomes, and offering evidence-based insights backed by extensive clinical validation. |
د.إ35,000.00
|
|
|
|
|
 |
Karyotyping – Products Of Conception (L)
Unlock critical genetic insights with **Karyotyping – Products of Conception (L)**, a specialized diagnostic test designed to analyze chromosomal abnormalities in fetal tissue following pregnancy loss. This advanced cytogenetic analysis provides essential information to help identify potential genetic causes of miscarriage, offering valuable guidance for future reproductive planning. |
د.إ2,400.00
|
|
|
|
|
 |
PCR FOR HLA B27 (EDTA)
PCR for HLA-B27 (EDTA) is a molecular diagnostic test used to detect the HLA-B27 gene, which is strongly associated with autoimmune disorders like ankylosing spondylitis and other spondyloarthropathies. Utilizing Polymerase Chain Reaction (PCR) technology, this test offers high sensitivity and specificity, ensuring accurate and reliable results. The use of EDTA as an anticoagulant preserves sample integrity, enhancing test precision. Key benefits include early disease detection, aiding in timely diagnosis and management of autoimmune conditions. Its rapid turnaround time and non-invasive nature make it a preferred choice for clinicians. |
د.إ2,400.00
|
|
|
|
|
 |
SPINAL MUSCULAR ATROPHY (SMA) Test – Fast & Accurate Genetic Screening
The **SPINAL MUSCULAR ATROPHY (SMA) Test** is a cutting-edge genetic screening tool designed to detect mutations in the **SMN1 gene**, the primary cause of SMA, a severe neuromuscular disorder. This highly accurate test enables **early diagnosis**, allowing for timely medical intervention and personalized treatment plans. It is **non-invasive**, requiring only a simple blood or saliva sample, and delivers **fast, reliable results**. Ideal for **newborn screening, carrier detection, and prenatal testing**, it empowers individuals and families with crucial genetic insights. With advanced technology ensuring **high sensitivity and specificity**, this test is a must-have for proactive healthcare and informed decision-making. |
د.إ2,000.00
|
|
|
|
|
 |
HIGH RESOLUTION-HLA A B C DR DQ DP TYPING
HIGH RESOLUTION-HLA A B C DR DQ DP TYPING is an advanced genetic test that provides precise, high-resolution typing of HLA Class I (A, B, C) and Class II (DR, DQ, DP) genes. It offers unparalleled accuracy in identifying HLA alleles, making it essential for organ and stem cell transplantation, disease association studies, and immunological research. Utilizing cutting-edge sequencing technology, this test ensures detailed allele-level resolution, improving donor-recipient matching and reducing transplant rejection risks. Its comprehensive coverage and high sensitivity make it a critical tool for personalized medicine, autoimmune disease research, and pharmacogenomics. |
د.إ4,200.00
|
|
|
|
|
 |
Fragile X (FMR1) Mutation Screen (L)
The Fragile X (FMR1) Mutation Screen (L) is a genetic test designed to detect mutations in the FMR1 gene, which are associated with Fragile X syndrome, a leading cause of inherited intellectual disability and autism. This screening identifies CGG repeat expansions, distinguishing between normal, premutation, and full mutation alleles. Key benefits include early detection for informed reproductive decisions, risk assessment for carriers, and guidance for personalized medical management. Utilizing advanced molecular techniques, the test ensures high accuracy and reliability. Ideal for individuals with a family history of Fragile X or unexplained developmental delays, this screening provides critical genetic insights for proactive healthcare planning. |
د.إ3,400.00
|
|
|
|
|
 |
Gut Microbiome Test
Unlock your gut’s potential with our Advanced Gut Microbiome Test . Get a personalized roadmap to optimize digestion, immunity, and overall wellness through cutting-edge microbial analysis and tailored recommendations. Easy, at-home testing with science-backed results. |
Original price was: د.إ4,750.00.د.إ1,999.00Current price is: د.إ1,999.00.
|
|